Quarterly report pursuant to Section 13 or 15(d)

Acquisition and Assets Held for Sale (Tables)

v3.23.3
Acquisition and Assets Held for Sale (Tables)
9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The allocation of the total purchase price of the CA Clinics Purchase was as follows:
Property and equipment $ 313,995 
Operating lease right-of-use asset 317,662 
Intangible assets 1,004,513 
Total assets acquired 1,636,170 
Deferred revenue (158,365)
Operating lease liability - current portion (118,081)
Operating lease liability - net of current portion (199,957)
Net purchase consideration $ 1,159,767 
The allocation of the total purchase price of the AZ Clinics Purchase was as follows:
Property and equipment $ 241,511 
Operating lease right-of-use asset 912,937 
Intangible assets 3,689,100 
Total identifiable assets acquired 4,843,548 
Goodwill 3,408,205 
Deferred revenue (455,317)
Operating lease liability - current portion (128,516)
Operating lease liability - net of current portion (784,722)
Net purchase consideration $ 6,883,198 
The allocation of the purchase price for the NC Clinics Purchase was as follows:

Property and equipment $ 142,395 
Operating lease right-of-use asset 122,641 
Intangible assets 1,299,607 
Total identifiable assets acquired 1,564,643 
Deferred revenue (153,176)
Operating lease liability - current portion (85,414)
Operating lease liability - net of current portion (40,388)
Net purchase consideration $ 1,285,665 
Schedule of Business Acquisition, Pro Forma Information
The following table summarizes selected unaudited pro forma consolidated income statements for the three and nine months ended September 30, 2023 and 2022 for the 2023 and 2022 acquisitions, as if the CA Clinics Purchase in 2023 and the NC Clinics Purchase in 2022 (which have been accounted for as an asset purchase) and the AZ Clinics Purchase in 2022 (which have been accounted for as a business combination) had all been completed on January 1, 2022.
Three Months Ended Nine Months Ended
September 30, September 30,
2023 2022 2023 2022
Revenues, net $ 29,473,949  $ 26,905,560  $ 87,820,694  $ 76,866,953 
Net income (703,681) 697,316  1,290,407  (491,325)
The Company’s condensed consolidated income statements for the three and nine months ended September 30, 2023 include net revenue and net income, excluding corporate clinic segment overhead costs, of the acquired California clinics as follows:
Three Months Ended Nine Months Ended
September 30, September 30,
2023 2023
Revenues, net $ 375,625  $ 544,344 
Net income 41,847  80,936 
Summary Of Assets And Liabilities Held For Sale
The principal components of the held for sale assets and liabilities as of September 30, 2023 were as follows:

September 30, 2023
Assets
Property and equipment, net
$ 2,153,454 
Operating lease right-of-use asset 2,204,293 
Intangible assets, net 386,280 
Goodwill 44,515 
Valuation allowance (816,429)
Total assets held for sale $ 3,972,113 
Liabilities
Operating lease liability, current and non-current $ 2,585,642 
Deferred revenue from company clinics 386,291 
Total liabilities to be disposed of $ 2,971,933